https://www.selleckchem.com/products/mm-102.html
prospective clinical study to explore the efficacy of temozolomide treatment in this patient population. The causative link between circulating glucocorticoid excess and osteoporosis is well-established. The enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), which increases local cortisol production, is expressed in human osteoblasts and its activity increases with age. We hypothesized that local 11β-HSD1 might mediate an age-related decrease in bone formation and that selective 11β-HSD1 inhibition may enhance bone formation. A d
Curtir
Comentario
Compartilhar
